126 related articles for article (PubMed ID: 7218250)
1. The hyperchemotaxis of Behcet's disease and the effect of colchicine.
Baum J
J Rheumatol; 1981; 8(1):171-2. PubMed ID: 7218250
[No Abstract] [Full Text] [Related]
2. Leucocyte movement and colchicine treatment in Behcet's disease.
Matsumura N; Mizushima Y
Lancet; 1975 Oct; 2(7939):813. PubMed ID: 78172
[No Abstract] [Full Text] [Related]
3. [Behçet's disease. Circulating immune complexes and abnormalities of polynuclear chemotaxis].
Graisely B; Margueritte-Renard O; Cloarec M; Debray J
Nouv Presse Med; 1979 Mar; 8(11):867. PubMed ID: 450661
[No Abstract] [Full Text] [Related]
4. Arthropathy of Behcet's disease with marked synovial pleocytosis responsive to colchicine.
Frayha RA
Arthritis Rheum; 1982 Feb; 25(2):235-6. PubMed ID: 7066056
[No Abstract] [Full Text] [Related]
5. Arachidonic acid metabolites and colchicine in Behçet's disease (BD).
Gürer MA; Keskin N; Gülekon A; Karel L; Aksakal B; Baysal V
Prostaglandins Leukot Essent Fatty Acids; 1991 Aug; 43(4):257-9. PubMed ID: 1946553
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of Behçet's syndrome with colchicine].
Pacor ML; Nicolis F; Peroli P; Urbani G; Cortina P; Corrocher R; Lunardi C
Riv Eur Sci Med Farmacol; 1989 Jun; 11(3):257-61. PubMed ID: 2640046
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of Behçet's disease with colchicine].
Török L; Egyedi K
Hautarzt; 1983 Feb; 34(2):87-8. PubMed ID: 6841085
[No Abstract] [Full Text] [Related]
8. Management of necrotizing vasculitis with colchicine. Improvement in patients with cutaneous lesions and Behcet's syndrome.
Hazen PG; Michel B
Arch Dermatol; 1979 Nov; 115(11):1303-6. PubMed ID: 507883
[TBL] [Abstract][Full Text] [Related]
9. [Colchicine in the treatment of Behçet's disease (author's transl)].
Mizushima Y; Matsumura N; Mori M; Matsumura Y; Shimizu T; Fukushima B; Mimura Y; Saito K; Sugiura S; Yamana S; Miyake S; Urayama A; Tanaka Y; Miyoshi K; Shirakami A
Ryumachi; 1978 Mar; 18(2):112-6. PubMed ID: 663792
[No Abstract] [Full Text] [Related]
10. [Behcet's disease. Trial treatment with colchicine].
Bennouna-Biaz F; Heid E; Lazrak B
Ann Dermatol Venereol; 1982; 109(6-7):593-4. PubMed ID: 7187187
[No Abstract] [Full Text] [Related]
11. The Effect of Colchicine on Mean Platelet Volume in Behcet's Disease.
Ataş H; Cemil BC; Canpolat F; Gönül M
Ann Clin Lab Sci; 2015; 45(5):545-9. PubMed ID: 26586706
[TBL] [Abstract][Full Text] [Related]
12. Behçet's syndrome: immune regulation, circulating immune complexes, neutrophil migration, and colchicine therapy.
Jorizzo JL; Hudson RD; Schmalstieg FC; Daniels JC; Apisarnthanarax P; Henry JC; Gonzalez EB; Ichikawa Y; Cavallo T
J Am Acad Dermatol; 1984 Feb; 10(2 Pt 1):205-14. PubMed ID: 6371066
[TBL] [Abstract][Full Text] [Related]
13. Behçet's syndrome treated with colchicine.
de Bois MH; Geelhoed-Duijvestijn PH; Westedt ML
Neth J Med; 1991 Apr; 38(3-4):175-6. PubMed ID: 1881506
[No Abstract] [Full Text] [Related]
14. The mechanism of hyperchemotaxis in Behçet's disease.
Takeuchi A; Kobayashi K; Mori M; Mizushima Y
J Rheumatol; 1981; 8(1):40-4. PubMed ID: 7218257
[TBL] [Abstract][Full Text] [Related]
15. [Use of colchicine in the treatment of Behçet's disease].
Gasparini G; Sambvani N; Contini D; Brigonzi A
G Ital Dermatol Venereol; 1985; 120(2):159-63. PubMed ID: 4007958
[No Abstract] [Full Text] [Related]
16. [Colchicine in Behcet's disease].
Haim S; Friedman-Birnbaum R
Harefuah; 1977 Dec; 93(12):399-400. PubMed ID: 611053
[No Abstract] [Full Text] [Related]
17. [Behçet's syndrome with amyloidosis. Report of a case. Clinical remission with colchicine].
Hamza M; Ben Maiz H; Ayed K; Ben Ayed H
Rev Rhum Mal Osteoartic; 1980 Jun; 47(6):431-3. PubMed ID: 7455603
[No Abstract] [Full Text] [Related]
18. Long-term effects of cyclophosphamide and colchicine treatment in Behçet's disease.
Kazokoglu H; Saatçi O; Cuhadaroglu H; Eldem B
Ann Ophthalmol; 1991 Apr; 23(4):148-51. PubMed ID: 2064258
[TBL] [Abstract][Full Text] [Related]
19. A double blind study of colchicine in Behçet's disease.
Aktulga E; Altaç M; Müftüoglu A; Ozyazgan Y; Pazarli H; Tüzün Y; Yalçin B; Yazici H; Yurdakul S
Haematologica; 1980 Jun; 65(3):399-402. PubMed ID: 6778795
[No Abstract] [Full Text] [Related]
20. Enhanced polymorphonuclear chemotaxis - a common feature of diseases responsive to colchicine.
Levy M; Ehrenfeld M; Gallily R; Eliakim M
Med Hypotheses; 1981 Jan; 7(1):15-20. PubMed ID: 7207280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
